Galectin-1 expression is also enhanced in stromal and endothelial cells, which are treated by conditioned media derived from ovarian and prostate cancer cells (58, 59), indicating the role of galectin-1 in the crosstalk of tumor cells with inflamed vasculature. Here, LGALS1 is linked to prostate cancer.